Owing to its predominant expression in neurodevelopment, SOX6 represents a putative tumor-specific antigen in glioma; treatment of mice with a SOX6-DNA vaccination had protective and anti-tumorigenic effects on tumor bearing mice (Ueda et al., 2004, 2008). The gene discussed is SOX6; the disease is neoplasm.